{"nct_id":"NCT05374603","title":"Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2022-11-23","start_date_type":"ACTUAL","primary_completion_date":"2025-08-30","primary_completion_date_type":"ESTIMATED","completion_date":"2025-08-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}